Tag: Pharmaceutical industry
von Roeder comes, Kuhnert goes
Frankfurt Only last Thursday did Helene von Roeder announce her imminent departure from the real estate group Vonovia. It is now clear where the Chief Digital Officer (CTO) is headed:…
Corona sales even higher than expected – oncology further strengthened
Biontech Biontech founders Özlem Türeci and Ugur Sahin (right). (Photo: dpa) Frankfurt As expected, business with Covid-19 vaccines fell sharply at Biontech in the first quarter. The Mainz-based company recorded…
Ozempic, Wegovy, Mounjaro: Diet drugs create stock hype
Ozempic and Mounjaro The drugs for diabetics are also prescribed as a means to lose weight. (Photo: Reuters) Frankfurt Lose weight without starvation diets or exercise? This is probably a…
Research-development country Germany
Dusseldorf, Brussels In no other country did companies increase their spending on research and development (R&D) as much as in the USA in the past year. Meanwhile, European companies are…
Cannabis legalization could bring the state more than a billion euros a year
Berlin No sale of joints in specialist shops, no commercial cultivation: the legalization of cannabis that Federal Minister of Health Karl Lauterbach (SPD) is aiming for is significantly less extensive…
Bayer closes mega energy deal in the US
Wind Turbines in Idaho Cat Creek Energy will invest around $1.5 billion in the US state. (Photo: Moment/Getty Images) Dusseldorf Bayer AG gains access to a mega-project for renewable energies…
Investors demand a fresh start at Bayer
Dusseldorf Norbert Winkeljohann, Chairman of the Bayer Supervisory Board, could hardly have paid the outgoing CEO any more respect: “Dear Mr. Bayer,” he called to Werner Baumann at the beginning…
“Patients in Europe do not want to be left behind”
Biotechnological Development Center Boehringer Ingelheim Julia Gueter is standing in a room with cell fermenters in the interdisciplinary development center for biotechnology of the pharmaceutical company Boehringer Ingelheim Pharma GmbH…
The good years are over for Merck
Merck in the balance sheet check In 2022, Merck generated sales of more than 20 billion euros for the first time. (Photo: dpa [M]) Frankfurt The Darmstadt-based Merck Group is…
“We want to see prices drop” – EU Commission wants to shorten protection periods for medicines
Brussels, Frankfurt Every centimeter of leeway has been used to advance health policy as far as possible, said Margaritis Schinas, Vice President of the EU Commission, when he presented proposals…
Everyone deals with this company on a daily basis without even knowing it
nantes The end of the pandemic is making itself felt in the balance sheets of Eurofins: Net profit fell by 23 percent to 606 million euros last year. This year,…
The EU is planning the biggest pharmaceutical reform in 20 years
Research at Bayer Like other sectors of the economy, the pharmaceutical industry is also feeling the effects of the significantly higher energy prices and higher costs for primary products. (Photo:…
Curevac pushes restart
Curevac The manager comes from Sanofi. (Photo: imago images/Eibner) Frankfurt The Tübingen-based biotech company Curevac intends to further advance the realignment of its research by starting additional clinical studies. The…
How the new CEO Bayer has to move forward
Bayer balance sheet The basic figures of the Dax group are solid. Nevertheless, questions remain. (Photo: mauritius images) Dusseldorf Bayer shareholders, who quickly expect the big hit after the change…
How the new CEO Bayer has to move forward
Bayer balance sheet The basic figures of the Dax group are solid. Nevertheless, questions remain. (Photo: mauritius images) Dusseldorf Bayer shareholders, who quickly expect the big hit after the change…
Birth control pills will be free in Italy
Birth control pills The use of contraceptives, especially the birth control pill, has always been low in Italy compared to other EU countries. (Photo: imago images/MiS) Rome In Italy, women…
Two Morphosys drugs are showing promise
Frankfurt After a long dry spell, the Munich-based biotech company Morphosys has regained some investor confidence with a number of positive reports. At a conference in the USA, the company…
Billion dollar deal for Munich biotech start-up Tubulis
Tubulis logo The young biotech company could earn over a billion dollars with the partnership. (Photo: tubules) Frankfurt The Munich-based biotech company Tubulis has agreed a potentially multi-billion dollar deal…
Bayer board of directors receives bonus despite high glyphosate costs – shareholders express clear criticism
Bayer CEO Werner Baumann: Dusseldorf The remuneration of Bayer’s board of management has met with ongoing criticism from investors and proxy advisors. Reason: In 2022, Bayer also had to deal…
The most successful German share divided the analysts
medicines in the pharmacy The online mail-order pharmacies serve only a small part of the market for prescription-only products. The proportion could increase with the e-prescription. At least that’s what…